MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Heat Biologics Company Profile (NASDAQ:HTBX)

Consensus Ratings for Heat Biologics (NASDAQ:HTBX) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $15.67 (2,238.66% upside)

Analysts' Ratings History for Heat Biologics (NASDAQ:HTBX)
Show:
DateFirmActionRatingPrice TargetActions
4/9/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/21/2016HC WainwrightReiterated RatingBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Noble FinancialReiterated RatingBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha